NO20025459L - Sulfonamidderivater - Google Patents

Sulfonamidderivater

Info

Publication number
NO20025459L
NO20025459L NO20025459A NO20025459A NO20025459L NO 20025459 L NO20025459 L NO 20025459L NO 20025459 A NO20025459 A NO 20025459A NO 20025459 A NO20025459 A NO 20025459A NO 20025459 L NO20025459 L NO 20025459L
Authority
NO
Norway
Prior art keywords
sulfonamide
Prior art date
Application number
NO20025459A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025459D0 (no
Inventor
Macklin Brian Arnold
Thomas John Bleisch
George William Cuff
Paul Leslie Ornstein
Dennis Michael Zimmerman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20025459D0 publication Critical patent/NO20025459D0/no
Publication of NO20025459L publication Critical patent/NO20025459L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20025459A 2000-05-19 2002-11-14 Sulfonamidderivater NO20025459L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20600300P 2000-05-19 2000-05-19
PCT/US2001/011747 WO2001090057A1 (en) 2000-05-19 2001-05-04 Sulfonamide derivatives

Publications (2)

Publication Number Publication Date
NO20025459D0 NO20025459D0 (no) 2002-11-14
NO20025459L true NO20025459L (no) 2002-11-14

Family

ID=22764580

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025459A NO20025459L (no) 2000-05-19 2002-11-14 Sulfonamidderivater

Country Status (24)

Country Link
US (1) US20030225163A1 (zh)
EP (1) EP1311474A1 (zh)
JP (1) JP2003534316A (zh)
KR (1) KR20030007644A (zh)
CN (1) CN1429205A (zh)
AR (1) AR035915A1 (zh)
AU (1) AU2001259053A1 (zh)
BR (1) BR0110874A (zh)
CA (1) CA2409830A1 (zh)
CZ (1) CZ20023797A3 (zh)
DZ (1) DZ3343A1 (zh)
EA (1) EA200201234A1 (zh)
EC (1) ECSP014078A (zh)
HR (1) HRP20020918A2 (zh)
HU (1) HUP0302255A3 (zh)
IL (1) IL152156A0 (zh)
MX (1) MXPA02010020A (zh)
NO (1) NO20025459L (zh)
PE (1) PE20020052A1 (zh)
PL (1) PL358180A1 (zh)
SK (1) SK16312002A3 (zh)
SV (1) SV2002000459A (zh)
WO (1) WO2001090057A1 (zh)
ZA (1) ZA200208749B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
US6984756B2 (en) 2000-05-19 2006-01-10 Eli Lilly And Company Process for preparing biphenyl compounds
AU2001274806A1 (en) 2000-06-13 2001-12-24 Eli Lilly And Company Sulfonamide derivatives
US20040235957A1 (en) * 2001-10-12 2004-11-25 David Bleakman Use of sulfonamide derivatives as pharmaceuticals compounds
WO2005013961A1 (en) * 2003-07-17 2005-02-17 Eli Lilly And Company Combination therapy for treatment of cognitive disorders or psychoses
AU2007333247B2 (en) * 2006-12-11 2012-06-07 Eli Lilly And Company AMPA receptor potentiators
AU2014277952A1 (en) 2013-06-13 2016-01-28 Veroscience Llc Compositions and methods for treating metabolic disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525099B1 (en) * 1998-07-31 2003-02-25 Eli Lilly And Company N-substituted sulfonamide derivatives

Also Published As

Publication number Publication date
SV2002000459A (es) 2002-07-03
NO20025459D0 (no) 2002-11-14
PE20020052A1 (es) 2002-02-02
ZA200208749B (en) 2004-01-30
PL358180A1 (en) 2004-08-09
WO2001090057A1 (en) 2001-11-29
HRP20020918A2 (en) 2004-02-29
EA200201234A1 (ru) 2003-04-24
CN1429205A (zh) 2003-07-09
EP1311474A1 (en) 2003-05-21
MXPA02010020A (es) 2003-02-12
ECSP014078A (es) 2002-02-25
CZ20023797A3 (cs) 2003-04-16
US20030225163A1 (en) 2003-12-04
SK16312002A3 (sk) 2003-05-02
JP2003534316A (ja) 2003-11-18
DZ3343A1 (fr) 2001-11-29
CA2409830A1 (en) 2001-11-29
IL152156A0 (en) 2003-05-29
HUP0302255A2 (hu) 2003-11-28
AR035915A1 (es) 2004-07-28
KR20030007644A (ko) 2003-01-23
AU2001259053A1 (en) 2001-12-03
HUP0302255A3 (en) 2005-11-28
BR0110874A (pt) 2003-02-11

Similar Documents

Publication Publication Date Title
ATE353895T1 (de) Sulfonamidether - substituierte imidazochinoline
ATE290000T1 (de) Muscarinagonisten
DE10136334B8 (de) Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
ATE312098T1 (de) Thiazinoxazolidinon
ATA2932001A (de) Schneefräse
DE60235536D1 (de) Sulfonamidderivate
ATE262530T1 (de) Indolochinazolinone
ATE298751T1 (de) 7-oxopyridoryrimidine
DE1274523T1 (de) Hochdruckumformspülanlage
DE10192638T1 (de) Bohrstangenladevorrichtung
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
ATE509008T1 (de) Sulfonylguanidine
DE60009651D1 (de) Hochfrequenzscalter
DE10196064T1 (de) Halbleiterfotodektionsgerät
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
NO20025533D0 (no) Sulfonamidderivater
AR027931A1 (es) Antitranspirantes
ATE476423T1 (de) Benzoylpyridazine
DE50007634D1 (de) Kardioplegieballonkatheter
DE10052925B4 (de) Schaukelbett
DE10195909T1 (de) Viehfüttervorrichtung
DE10085445T1 (de) Drahterodierbearbeitungseinrichtung
NO20025459L (no) Sulfonamidderivater
AR027982A1 (es) Aril- y heteroarilsulfonatos
DE10195992T1 (de) Oberflächenendbearbeitungsbelag

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application